Virtu Financial LLC Applied Genetic Technologies Corp Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.29 - $0.89 $30,647 - $94,056	105,681 Added 977.89%	116,488 $32,000
Q2 2022 Aug 09, 2022	SELL	$0.62 - $1.1 $36,772 - $65,241	-59,310 Reduced 84.59%	10,807 $8,000
Q1 2022 May 17, 2022	BUY	$1.07 - $2.71 $75,025 - $190,017	70,117 New	70,117 $75,000
Q2 2021 Sep 17, 2021	SELL	$3.62 - $5.23 $45,061 - $65,103	-12,448 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$3.94 - $8.19 $142,746 - $296,723	-36,230 Reduced 74.43%	12,448 $63,000
Q4 2020 Feb 24, 2021	BUY	$3.99 - $5.7 $194,225 - $277,464	48,678 New	48,678 $199,000
Q3 2020 Dec 11, 2020	SELL	$4.38 - $6.43 $50,365 - $73,938	-11,499 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$3.0 - $6.9 $34,497 - $79,343	11,499 New	11,499 $64,000
Q3 2019 Nov 20, 2019	SELL	$2.59 - $4.16 $26,469 - $42,515	-10,220 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$3.6 - $4.78 $36,792 - $48,851	10,220 New	10,220 $39,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.